Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
Authors
Daniel Aaron Fox
Baylor College of Medicine, Houston, TX
Daniel Aaron Fox , Deepak Bhamidipati , Funda Meric-Bernstam , Shubham Pant , Jeffrey S. Ross , Zishuo Ian Hu , Eugene Jon Koay , Ethan B. Ludmir , Hop Sanderson Tran Cao , Ching-Wei D. Tzeng , Yun Shin Chun , Jean-Nicolas Vauthey , Timothy E. Newhook , Zeyad Metwalli , Peiman Habibollahi , Veronica L. Cox , Hyunseon Kang , Milind M. Javle , Sunyoung S. Lee , Jaime Haro-Silerio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 492)
DOI
10.1200/JCO.2024.42.3_suppl.492
Abstract #
492
Poster Bd #
C17
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
First Author: Kumiko Umemoto
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2020 ASCO Virtual Scientific Program
Genomics and translational precision oncology for 803 patients with biliary tract cancer.
First Author: Jianzhen Lin